A detailed history of J. Goldman & CO LP transactions in Galapagos Nv stock. As of the latest transaction made, J. Goldman & CO LP holds 84,307 shares of GLPG stock, worth $2.26 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
84,307
Holding current value
$2.26 Million
% of portfolio
0.06%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$22.69 - $28.79 $1.91 Million - $2.43 Million
84,307 New
84,307 $2.12 Million
Q1 2022

May 16, 2022

SELL
$51.32 - $68.5 $1.44 Million - $1.92 Million
-27,972 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$47.03 - $57.12 $1.32 Million - $1.6 Million
27,972 New
27,972 $1.54 Million

Others Institutions Holding GLPG

About GALAPAGOS NV


  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.77B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track J. Goldman & CO LP Portfolio

Follow J. Goldman & CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on J. Goldman & CO LP with notifications on news.